The Latest Cardiac and Vascular News
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assumption of certain liabilities and seller’s retention of certain working capital accounts. The transaction is expected to close […]
VANCOUVER and MINNEAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights Generated revenue of $514,000 in the quarter and $1.96 million for the full year as Reducer […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. announced today that Lisa Anderson, Ph.D., has been elevated to the role of CEO. Dr. Anderson succeeds William Edelman, who has served as Chairman and CEO since 2012 and recently announced his retirement. John Cammett, member of the Board for over three years, will assume the […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a commercial scale supply agreement for the production of bentracimab, PhaseBio’s […]
WARREN, N.J., March 11, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the fourth quarter and year ended December 31, 2020. “Bellerophon continues […]
– Dr. Hans-Peter Stoll is an interventional cardiologist and senior medical executive with 20 years of leadership experience who has demonstrated deep expertise in clinical strategy and execution. – Dr. Stoll supports and expands MCRA’s specialization in cardiology and clinical trial management globally. WASHINGTON, March 11, 2021 /PRNewswire/ — MCRA, LLC, a […]
FARMINGTON, Conn., March 9, 2021 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today it has provided a $9 million venture loan […]
2020 Total Revenue was $41.0 million, with 2020 Product Sales of $39.5 million, up 73% over 2019. Achieved record Product Gross Margins of 82% for Q4 2020 MONMOUTH JUNCTION, N.J., March 9, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill […]
NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: iRhythm Technologies (NASDAQ: IRTC) Reliq Health Technologies (OTC:RQHTF) (TSX.V:RHT), Relay Medical (CSE: RELA) (OTC: RYMDF) and AdaptHealth Corp. (NASDAQ: […]
Record Quarterly Revenue of $29.3 million in Q4 2020, up 149% year over year and up 22% from Q3 2020 Operating loss of $1.8 million in Q4 2020, a 74% improvement year over year Record Quarterly Adjusted EBITDA of $2.2 million in Q4 2020, achieving positive quarterly Adjusted EBITDA for […]
